Asian Paints. Source: Company Data; PL Research

Similar documents
Asian Paints. Source: Company Data; PL Research

Britannia Industries

Mahindra & Mahindra. Source: Company Data; PL Research

TVS Motors. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Cummins India. Source: Company Data; PL Research

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research

Siemens. Railways and T&D driving inflows. Source: Company Data; PL Research

SpiceJet. Healthy operating performance in Q2. Source: Company Data; PL Research

Bharat Petroleum Corporation

Thermax. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Crompton Greaves. Looking to exit overseas Power segment! Source: Company Data; PL Research

Source: Company Data; PL Research

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

Indraprastha Gas. Growth traction continues. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

JK Lakshmi Cement. Source: Company Data; PL Research

Maruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research

Eicher Motors. Continues to ride high! Accumulate. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Allcargo Logistics. Source: Company Data; PL Research

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research

Bharat Electronics. Best defence play. Source: Company Data; PL Research

Hindustan Unilever. In the Pink of Health ; Accumulate. Source: Company Data; PL Research

Reliance Industries. Impressive performance. Source: Company Data; PL Research

Larsen & Toubro. Decent performance! Source: Company Data; PL Research

Dabur India. Source: Company Data; PL Research

Hindalco Industries. Source: Company Data; PL Research

Mphasis. Source: Company Data; PL Research

Dabur India. Worst is over; Accumulate. Source: Company Data; PL Research

Colgate Palmolive. Source: Company Data; PL Research

Ashok Leyland. Source: Company Data; PL Research

Jindal Steel & Power

Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Cadila Healthcare. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

Navneet Education. ILL loss hurts consolidated earnings growth. Source: Company Data; PL Research

Ultratech Cement. Source: Company Data; PL Research

Eicher Motors. Source: Company Data; PL Research

Tech Mahindra. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Hindustan Zinc. Source: Company Data; PL Research

Dr. Lal PathLabs. Source: Company Data; PL Research

Va Tech Wabag. On track for a strong H2FY16. Source: Company Data; PL Research

Indraprastha Gas. Source: Company Data; PL Research

Bharat Forge. Growth on all fronts; Accumulate. Source: Company Data; PL Research

Britannia Industries

Aurobindo Pharma. Source: Company Data; PL Research

Cummins India. Focusing on growth in core segments. Source: Company Data; PL Research

Sonata Software. Strong growth, reasonable valuations. Source: Company Data; PL Research

Dabur India. Share gains power growth, Accumulate. Source: Company Data; PL Research

Dabur India. Steady recovery in place; Accumulate. Source: Company Data; PL Research

Marico. Source: Company Data; PL Research

Jindal Steel & Power

Glenmark Pharmaceuticals

S Chand and Company. TP of Rs679 (implying PER of 20x FY19E earnings) Source: Company Data; PL Research

Source: Company Data; PL Research

Aurobindo Pharma. Source: Company Data; PL Research

Larsen & Toubro. Source: Company Data; PL Research

Tata Motors. Turnaround 2.0, Fit for future; BUY. Source: Company Data; PL Research

LIC Housing Finance. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276

Colgate Palmolive. Source: Company Data; PL Research

HDFC Standard Life Insurance

Tata Steel. Source: Company Data; PL Research

ICICI Prudential Life Insurance

VRL Logistics. Steady show in tough environment. Source: Company Data; PL Research

Dr. Reddy's Laboratories

Need to pull up the socks. Source: Company Data; PL Research

NIIT Technologies. Source: Company Data; PL Research

Cig volumes surprise. Source: Company Data; PL Research

Glenmark Pharmaceuticals

Cadila Healthcare. Source: Company Data; PL Research

Punjab National Bank

Cadila Healthcare. Source: Company Data; PL Research

Dr. Reddy's Laboratories

Bayer Cropscience (BYRCS IN)

GMR Infrastructure. Airport revenues on a thaw, Power awaiting its turn. Q3FY13 Result Update

Capital First. Continuing to grow strong. Source: Company Data; PL Research

IDEA RESEARCH. Q2FY19 Result Update Tuesday, November 13, Mold Tek Packaging Lower gross margins & higher interest cost impacts profitability

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018

Punjab National Bank

Glenmark Pharmaceuticals

Bharat Forge. Strong traction in exports. (our estimate Rs730m). Source: Company Data; PL Research

Gujarat State Fertilisers & Chemicals

Lupin Result beats expectations; Near term revenue drivers improves grows visibility

Pantaloon Retail India

LIC Housing Finance. Stable performance. Source: Company Data; PL Research

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840

Aurobindo Pharma. Source: Company Data; PL Research

Hindustan Zinc. Strong show, H2 to be stronger than H1. Source: Company Data; PL Research

FY20E FY21E FY20E FY21E

Transcription:

Premium valuations to sustain, Accumulate October 4, 17 Amnish Aggarwal amnishaggarwal@plindia.com +91 Gaurav Jogani gauravjogani@plindia.com +91 8 Rating Accumulate Price Rs1,1 Target Price Rs1,9 Implied Upside 1.% Sensex,7 Nifty 1,8 (Prices as on October 4, 17) Trading data Market Cap. (Rs bn) 1,17.7 Shares o/s (m) 99. M Avg. Daily value (Rs m) 119.4 Major shareholders Promoters.79% Foreign 17.8% Domestic Inst. 9.% Public & Other.% Stock Performance (%) 1M M 1M Absolute.4 14.4 8.4 Relative (1.7) 4. (7.) How we differ from Consensus EPS (Rs) PL Cons. % Diff. 18.4.4 4. 19 8..7.8 Price Performance (RIC: ASPN.BO, BB: APNT IN) (Rs) 1,4 1, 1, 8 4 Oct 1 Source: Bloomberg Feb 17 Apr 17 Aug 17 Oct 17 APNT reported high single digit volume growth in domestic decorative business in QFY18 as post GST recovery and festival demand was visible only from September 17. Gross margins in Q declined by 1bps YoY due to carry over input cost inventory till August end, despite some softening in Q. We expect HFY18 growth to accelerate, given low base due to demonetisation in QFY17 and expected pickup in demand. We expect mid teens volume growth in the decorative paints for the coming 1 years led by rising consumerism, reduced painting cycles and increased application in small towns and rural India. We expect premium valuations to sustain and retain Accumulate with target price of Rs1,9 (Rs1 earlier). We expect returns to be back ended, given all time high valuations. Conference Call Highlights: 1) First half of QFY18 was impacted due to GST, while recovery was seen from September 17. October performance was below expectation due to extended monsoons which impacted demand for exterior paints ) APNT has discontinued production of Phthalic Anhydride at Ankleshwar and will set up a pain unit at the same site ) Manufacturing unit in Indonesia has started production in QFY18; products will be marketed under Asian Paints 4) APNT has guided for capex of Rs1bn in FY18, out of which, Rs1bn will be spent on Vizag and Mysuru plant; work is heading as per schedule and is expected to start from FY19 ) Raw material usage prices were up in July and August because margins were impacted in Q 7) APNT has not taken any price increase in July despite high raw material prices as appreciating Rupee has provided some cushion 8) Other income was lower as there was a higher dividend received in QFY17 and also due to lower investible cash 9) Dealer addition of 4k k per year may be lower in FY18 due to GST implementation 1) Demand in Egypt and Ethiopia has been impacted due to currency issues. Key financials (Y/e March) 1 17 18E 19E Revenues (Rs m) 8, 17,848,79,8 Growth (%).8 7.8 17. 17. EBITDA (Rs m) 7,8,14 4,47 41,4 PAT (Rs m) 17,9 19,178,44 7,8 EPS (Rs) 18.7..4 8. Growth (%)..8 1.8.8 Net DPS (Rs) 7. 1... Profitability & Valuation 1 17 18E 19E EBITDA margin (%) 17. 17.7 17.1 17. RoE (%) 4.7.. 4. RoCE (%). 9.9.7.1 EV / sales (x) 7..7.8 4.9 EV / EBITDA (x) 41.7 8.1. 7. PE (x). 1.. 4. P / BV (x).9 18.4.9.7 Net dividend yield (%)..8.9 1.1 Source: Company Data; PL Research QFY18 Result Update Prabhudas Lilladher Pvt. Ltd. and/or its associates (the 'Firm') does and/or seeks to do business with companies covered in its research reports. As a result investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of the report. Investors should consider this report as only a single factor in making their investment decision. Please refer to important disclosures and disclaimers at the end of the report

Exhibit 1: QFY18 Results Consolidated (Rs m): Adj. PAT up 8.1% on % sales growth Y/e March QFY18 QFY17 YoY gr. (%) Q1FY17 H1FY18 H1FY17 YoY gr.(%) Net Sales 4, 7,9. 8, 8,8 7,49 1. Gross Profit 17,1 1,48 7. 1,4,9,41.9 % of NS 41. 44.4 4.8 4. 4.8 Other Expenses 9,99 9,44.1 9,8 19,8 18,84 4.9 % of NS..4.4.9. EBITDA 8, 7,4.,4 14,,7.9 Margins (%) 18.8 19. 17.4 18.1.8 Depreciation 889 8.8 9 1,794 1,88. Interest 88 9 48.9 8 17 1. Other Income 4 79 (.) 78 1,17 1,1 (1.8) PBT 7,9,9 8.8,4 14,1 14,98 (.) Tax,49,.8,1 4,19 4,8 (.8) Tax rate (%). 1...9.1 Adjusted PAT,84 4,74 8.1 4,49 9, 1, (7.) Exhibit : QFY18 Results Standalone (Rs m); Adj. PAT up 8.8% even as GM declines bps, volumes up ~9% Y/e March QFY18 QFY17 YoY gr. (%) Q1FY18 H1FY18 H1FY17 YoY gr. (%) Net Sales, 1, 1.1,9 8,1,88.8 Gross Profit, 14,11 7.4 14,1 9,9 8,.1 % of NS 4. 4.7 4.8 4. 47. Other Expenses 8,1 7,849.1 8,4 1,7,9 7. % of NS...1. 4.7 EBITDA 7,1,1 14.1,971,17,14 (.) Margins (%).. 18. 19.4.4 Depreciation 77 71. 78 1,9 1,471.9 Interest 44. 4 9 8 7.9 Other Income 8 848 (4.7) 81 1, 1, (8.) PBT 7,18,8 9.9,,,9 (4.7) Tax,84, 1., 4, 4,8 (.) Tax rate (%). 1.8.. 1. Adjusted PAT 4,7 4, 8.8 4,1 8,744 9, (.) Consolidated Net sales increased % to Rs4.bn. Gross margin declined 1bps YoY (bps QoQ); EBITDA increased.% as margins declined bps to 18.8%. Adj. PAT increased by 8.1% at Rs.8bn as tax rate increased by 9bps. Standalone sales increased by 1.1% to Rs.bn due to high single digit volume growth in decorative business. Gross margin declined bps YoY (down 1bps QoQ); EBITDA margins declined bps YoY to %. Adj. PAT increased by 8.8% to Rs4.7bn due to 7bps higher tax rate. Home improvement business of Sleek and ESS reported % increase in sales and.1% increase in losses. October 4, 17

Exhibit : Volumes up by 9% as recovery began in September 17 Volume Growth (%) Realization Growth (%) 4 1 1 9 1 1 1 7 4 9 4 8 4 1 1 1 Dec 9 17 Jun 1 7 Dec 1 1 1 18 Jun Dec Jun 1 Dec 1 7 17 Jun Dec Jun 14 Dec 14 8 Jun 1 Dec Jun 1 9 Exhibit 4: APNT increased decorative prices by.7% in CY17 Exhibit : Tio prices up by 14.% YoY and down 7.7% QoQ. 4... 1.. 1... May 1 Aug 1 Mar Jun Nov Feb 1 May 1.1 1.8 1.1. 1. 1.. May Sep May 14.. Feb Mar 17.7 4... 1.. 1.. 7. Sep 17 8.9 Mar 17 TiO YoY Price change % Sep 1 Jun 1 Mar 1 Dec Sep Jun.. Mar Dec 14 Sep 14 October 4, 17

Income Statement (Rs m) Net Revenue 8, 17,848,79,8 Raw Material Expenses 9,8 1, 11,9 144,4 Gross Profit,14 8,9 78,89 91,74 Employee Cost 9,9 1,8 1,79 14, Other Expenses 4,78 7,18 1,74,7 EBITDA 7,8,14 4,47 41,4 Depr. & Amortization,7,88,44,788 Net Interest 47 Other Income,4,,8,84 Profit before Tax, 9,14,1 4,1 Total Tax 8,444 9,48 1,44 1,1 Profit after Tax 18, 19,,89 7,48 Ex Od items / Min. Int. (4) 4 9 1,47 Adj. PAT 17,9 19,178,44 7,8 Avg. Shares O/S (m) 99. 99. 99. 99. EPS (Rs.) 18.7..4 8. Cash Flow Abstract (Rs m) C/F from Operations,87,719,74,48 C/F from Investing (,417) (14,) (1,8) (17,4) C/F from Financing (9,71) (,1) (1,714) (,) Inc. / Dec. in Cash 1,89 (177) 7 178 Opening Cash,7,41,4 4,48 Closing Cash,8,9 4,1 4, FCFF,787 19,47 1,4 17,48 FCFE 14,81 19,7 1,4 17,48 Key Financial Metrics Growth Revenue (%).8 7.8 17. 17. EBITDA (%).8 9.1.9.8 PAT (%)..8 1.8.8 EPS (%)..8 1.8.8 Profitability EBITDA Margin (%) 17. 17.7 17.1 17. PAT Margin (%).... RoCE (%). 9.9.7.1 RoE (%) 4.7.. 4. Balance Sheet Net Debt : Equity (.) (.) (.) (.) Net Wrkng Cap. (days) () () Valuation PER (x). 1.. 4. P / B (x).9 18.4.9.7 EV / EBITDA (x) 41.7 8.1. 7. EV / Sales (x) 7..7.8 4.9 Earnings Quality Eff. Tax Rate 1.7. 1. 1. Other Inc / PBT 8. 9. 7..7 Eff. Depr. Rate (%)..4.1.4 FCFE / PAT 8.7 1.8 9.7 4.. Balance Sheet Abstract (Rs m) Shareholder's Funds,98,78 7,47 8,17 Total Debt,,,, Other Liabilities,,974 7,79 8,44 Total Liabilities 4, 7,8 84,4 97,41 Net Fixed Assets,1 7,77 48, 4,48 Goodwill 1,977 1,977 1,977 1,977 Investments,9 7,817 9,817,817 Net Current Assets,81,887,4 9,79 Cash & Equivalents 19,794,7 19,84,41 Other Current Assets 41,4,7 9, 8,9 Current Liabilities 7,7 47,1 4,7 4,98 Other Assets Total Assets 4, 7,8 84,4 97,41 Quarterly Financials (Rs m) Y/e March QFY17 Q4FY17 Q1FY18 QFY18 Net Revenue 9,7 9, 8, 4, EBITDA 7,7 7,9,4 8, % of revenue 19.7 18. 17.4 18.8 Depr. & Amortization 8 8 9 889 Net Interest 9 9 8 88 Other Income 4 71 78 4 Profit before Tax 7,1,89,4 7,9 Total Tax,4,,1,49 Profit after Tax 4, 4,79 4,49 4,41 Adj. PAT 4, 4,79 4,49,84 Key Operating Metrics Decorative Volume Growth %. 8... Gross Margins % 9. 4. 9. 8.9. October 4, 17 4

Prabhudas Lilladher Pvt. Ltd. rd Floor, Sadhana House, 7, P. B. Marg, Worli, Mumbai 4 18, India Tel: (91 ) Fax: (91 ) 9 Rating Distribution of Research Coverage PL s Recommendation Nomenclature % of Total Coverage % 4% % % 1% % 4.8% 9.1% 17.%.% BUY Accumulate Reduce Sell BUY : Over % Outperformance to Sensex over 1 months Accumulate : Outperformance to Sensex over 1 months Reduce : Underperformance to Sensex over 1 months Sell : Over % underperformance to Sensex over 1 months Trading Buy : Over 1% absolute upside in 1 month Trading Sell : Over 1% absolute decline in 1 month Not Rated (NR) : No specific call on the stock Under Review (UR) : Rating likely to change shortly DISCLAIMER/DISCLOSURES ANALYST CERTIFICATION We/I, Mr. Amnish Aggarwal (MBA, CFA), Mr. Gaurav Jogani (MBA, Bcom), Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Terms & conditions and other disclosures: Prabhudas Lilladher Pvt. Ltd, Mumbai, India (hereinafter referred to as PL ) is engaged in the business of Stock Broking, Portfolio Manager, Depository Participant and distribution for third party financial products. PL is a subsidiary of Prabhudas Lilladher Advisory Services Pvt Ltd. which has its various subsidiaries engaged in business of commodity broking, investment banking, financial services (margin funding) and distribution of third party financial/other products, details in respect of which are available at www.plindia.com This document has been prepared by the Research Division of PL and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of PL. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy or completeness of the same. Neither PL nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient's particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor. Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or engage in transactions of securities of companies referred to in this report and they may have used the research material prior to publication. PL may from time to time solicit or perform investment banking or other services for any company mentioned in this document. PL is in the process of applying for certificate of registration as Research Analyst under Securities and Exchange Board of India (Research Analysts) Regulations, 14 PL submits that no material disciplinary action has been taken on us by any Regulatory Authority impacting Equity Research Analysis activities. PL or its research analysts or its associates or his relatives do not have any financial interest in the subject company. PL or its research analysts or its associates or his relatives do not have actual/beneficial ownership of one per cent or more securities of the subject company at the end of the month immediately preceding the date of publication of the research report. PL or its research analysts or its associates or his relatives do not have any material conflict of interest at the time of publication of the research report. PL or its associates might have received compensation from the subject company in the past twelve months. PL or its associates might have managed or co managed public offering of securities for the subject company in the past twelve months or mandated by the subject company for any other assignment in the past twelve months. PL or its associates might have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months. PL or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months PL or its associates might have received any compensation or other benefits from the subject company or third party in connection with the research report. PL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. PL or its analysts did not receive any compensation or other benefits from the subject Company or third party in connection with the preparation of the research report. PL or its Research Analysts do not have any material conflict of interest at the time of publication of this report. It is confirmed that Mr. Amnish Aggarwal (MBA, CFA), Mr. Gaurav Jogani (MBA, Bcom), Research Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. The Research analysts for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. The research analysts for this report has not served as an officer, director or employee of the subject company PL or its research analysts have not engaged in market making activity for the subject company Our sales people, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest. PL and its associates, their directors and employees may (a) from time to time, have a long or short position in, and buy or sell the securities of the subject company or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company or act as an advisor or lender/borrower to the subject company or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. DISCLAIMER/DISCLOSURES (FOR US CLIENTS) ANALYST CERTIFICATION The research analysts, with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is or will be directly related to the specific recommendation or views expressed in this research report Terms & conditions and other disclosures: This research report is a product of Prabhudas Lilladher Pvt. Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Prabhudas Lilladher Pvt. Ltd. only to "Major Institutional Investors" as defined by Rule a (b)(4) of the U.S. Securities and Exchange Act, 194 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule a (a)(). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional Investor. In reliance on the exemption from registration provided by Rule a of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Prabhudas Lilladher Pvt. Ltd. has entered into an agreement with a U.S. registered broker dealer, Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer. October 4, 17